Related Experiment Video
Updated: Dec 12, 2025

Inkjet-printed Polyvinyl Alcohol Multilayers
Published on: May 11, 2017
Application of polyvinyl acetate in an innovative formulation strategy for lyophilized orally disintegrating tablets
Brecht Vanbillemont1, Thomas De Beer1
1Laboratory of Pharmaceutical Process Analytical Technology (LPPAT), Department of Pharmaceutical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.
Abstract:
Orally disintegrating tablets (ODTs) manufactured by freeze-drying, also called oral lyophilizates, are a patient-centred dosage form. They possess ultra-fast disintegration dynamics, have acceptable mechanical strength and have a smooth mouth texture. In this study, polyvinyl alcohol (PVA) was investigated as an alternative polymeric binder to gelatin for ODT formulations. A low- and high-dose formulation were in-scope with mannitol as filler and xanthan gum as a viscosity enhancer. Design of experiments (DoE) methodology was applied to study the formulation effects on several quality attributes. Sedimentation during the initial phases of freeze-drying was successfully measured using Raman spectroscopy and could be minimized by adjusting the xanthan gum concentration. Multiple linear regression models were subsequently applied to establish design spaces and robust optimised formulations. A 19 mg hydrochlorothiazide (HCT) as low-dose and 500 mg paracetamol as high-dose ODT were developed in this study. The work displayed the use of PVA as a viable polymeric binder, and alternative for gelatin, in lyophilized ODTs.
More Related Videos
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
In Vitro Drug Dissolution: Alternative Methods
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
In Vitro Drug Dissolution: Compendial Testing Models I

